New Commercial Partnership in Sweden

AI SummaryClose X

ProBiotix Health PLC announced a commercial partnership with RevivaBio, a Swedish health company, to launch a new cholesterol-lowering product. The product will feature ProBiotix's patented probiotic strain LPLDL®. RevivaBio's new capsule dietary supplement will be introduced and launched in Sweden and several APAC markets during Q1 2026 under RevivaBio's brand, distributed through health stores and e-commerce. ProBiotix will manufacture the primary finished capsules, while RevivaBio will handle the final packaging. RevivaBio was recommended on Sweden's leading review platform, Reco.se, for seven consecutive years, with an average customer rating of 4.6 out of 5 from over 700 verified reviews.

Disclaimer*

UK 100

Latest directors dealings